Table 3.
MICs for 30 C. difficile isolates with antibiotic resistancesa
R.M. Alden strain | Phenotype | MIC (μg/ml) |
|||
---|---|---|---|---|---|
MBX-500 | Moxi | Vanco | Metro | ||
QC strain | Sensitive | 2 | 2 | 1 | 0.5 |
8826 | Err Clr Ter | 4 | 32 | 1 | 0.25 |
8827 | Err Clr Syr | 4 | 32 | 1 | 0.25 |
8830 | Err Clr Ter | 4 | 32 | 1 | 0.25 |
8831 | Err | 4 | 2 | 1 | 0.25 |
8832 | Err Clr Syr Lzr | 2 | 2 | 1 | 0.25 |
8834 | Err Clr Syr Imr Ter Lzr | 4 | 32 | 1 | 0.5 |
9400 | Err Clr Syr Ter | 2 | 32 | 1 | 0.25 |
10540 | Err Clr Ter | 1 | 2 | 1 | 0.5 |
11788 | Err Imr | 2 | 32 | 4 | 1 |
12019 | Ter | 2 | 2 | 0.5 | 0.25 |
13879 | Err Clr Syr Imr Ter | 4 | 32 | 1 | 0.5 |
16277 | Err Clr Syr | 4 | 32 | 4 | 0.25 |
16278 | Err Clr Syr Lzr | 2 | 32 | 4 | 0.25 |
16282 | Clr Imr Lzr | 4 | 32 | 1 | 0.25 |
16286 | Err Clr Syr Lzr | 2 | 32 | 1 | 0.25 |
16458 | Clr Lzr | 2 | 32 | 1 | 0.5 |
19556 | NAP1/027 | 2 | 32 | 1 | 2 |
19560 | NAP1/027 | 2 | 64 | 1 | 2 |
19562 | NAP1/027 | 2 | 64 | 1 | 2 |
19565 | NAP1/027 | 2 | 32 | 1 | 1 |
19566 | NAP1/027 | 2 | 32 | 1 | 1 |
19567 | NAP1/027 | 2 | 16 | 1 | 1 |
19569 | NAP1/027 | 2 | 32 | 1 | 1 |
19571 | NAP1/027 | 2 | 32 | 2 | 1 |
19574 | NAP1/027 | 2 | 64 | 1 | 2 |
19575 | NAP1/027 | 2 | 64 | 1 | 2 |
19643 | NAP1/027 | 2 | 32 | 1 | 1 |
19645 | NAP1/027 | 4 | 16 | 4 | 1 |
19646 | NAP1/027 | 2 | 32 | 1 | 4 |
19647 | NAP1/027 | 2 | 32 | 1 | 1 |
MIC90 | 4 | 64 | 4 | 2 | |
MIC50 | 2 | 32 | 1 | 1 | |
MIC range | 1–4 | 2–64 | 0.5–4 | 0.25–4 |
r, resistant; Er, erythromycin; Cl, clindamycin; Te, tetracycline; Sy, synercid; Lz, linezolid; Im, imipenem; NAP1/027, North American pulse-field type 1, ribotype 27; Moxi, moxifloxacin; Vanco, vancomycin; Metro, metronidazole.